On Thursday, Shares of News Corporation (NASDAQ:NWSA), lost -0.13% to $14.97.
News Corporation, stated fiscal 2015 third quarter total revenues of $2.06 billion, a 1% decline as contrast to preceding year third quarter revenues of $2.08 billion. The majority of the revenue decline reflects negative foreign currency fluctuations and lower advertising revenues at the News and Information Services segment, offset in large part by growth in the Book Publishing and Digital Real Estate Services segments as a result of the acquisition of Harlequin Enterprises Limited and Move, Inc., respectively. Adjusted revenues declined 2% contrast to the preceding year.
The Company stated third quarter Total Segment EBITDA of $163 million, a 7% decline as contrast to $175 million in the preceding year. These results comprise $15 million and $20 million in fees and costs – net of indemnification – related to the U.K. Newspaper Matters in the three months ended March 31, 2015 and 2014, respectively. Declines at the News and Information Services segment, counting higher legal costs at News America Marketing, negative foreign currency fluctuations and raised stock-based compensation expense resulting from the acquisition of Move were partially offset by lower expenses at Amplify and raised revenues in the Book Publishing segment due to the inclusion of Harlequin results. Adjusted Total Segment EBITDA declined 1% contrast to the preceding year.
News Corporation, a media and information services company, focuses on creating and distributing authoritative and engaging content to consumers and businesses worldwide. The company operates through News and Information Services, Cable Network Programming, Digital Real Estate Services, Book Publishing, and Digital Education segments.
Shares of Amedica Corporation (NASDAQ:AMDA), surged 26.59% to $0.32, during its last trading session.
Amedica Corporation, declared financial results for the first quarter ended March 31, 2015.
First Quarter 2015 Highlights
- Accomplished SNAP clinical trial enrollment
- Presented for 510(k) clearance of cervical CsC device
- Kyocera officially named as approved secondary supplier of silicon nitride devices
- Continued robust scientific publication strategy of one peer-reviewed publication per month
- Began two feasibility studies and advanced several OEM and Private Label discussions.
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America.
At the end of Thursday’s trade, Shares of National Oilwell Varco, Inc. (NYSE:NOV), lost -4.68% to $51.97.
National Oilwell Varco, will hold a conference call on Tuesday, July 28, 2015 at 8:00 am (Central Time) to talk about results for the second quarter of 2015.
National Oilwell Varco, Inc. designs, manufactures, and sells equipment and components used in oil and gas drilling, completion, and production; and provides oilfield services to the upstream oil and gas industry worldwide.
Finally, Vipshop Holdings Limited (NYSE:VIPS), ended its last trade with 1.11% gain, and closed at $27.32.
Vipshop Holdings Limited, declared that it plans to release its first quarter 2015 financial results on Wednesday, May 13, 2015 after market close. The Company will hold a conference call on Thursday, May 14, 2015 at 8:00 am Eastern Time or 8:00 pm Beijing Time to talk about the financial results.
Vipshop Holdings Limited, through its auxiliaries, operates as an online discount retailer for various brands in the People’s Republic of China. It offers a range of branded products, counting apparel for women, men, and children; fashion goods; cosmetics; home goods and other lifestyle products; footwear; sportswear and sporting goods; luxury goods; and gifts and miscellaneous products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
